These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28828165)

  • 1. Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation.
    Mohammadi Najafabadi M; Shamsasenjan K; Akbarzadehalaleh P
    Int J Organ Transplant Med; 2017; 8(2):57-67. PubMed ID: 28828165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiogenesis in patients with hematologic malignancies].
    Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
    Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML.
    Koenecke C; Kümpers P; Lukasz A; Dammann E; Verhagen W; Göhring G; Buchholz S; Krauter J; Eder M; Schlegelberger B; Ganser A
    Ann Hematol; 2010 May; 89(5):459-67. PubMed ID: 20054548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
    Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
    Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome.
    Albitar M
    Acta Haematol; 2001; 106(4):170-6. PubMed ID: 11815714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia.
    Hilger N; Mueller C; Stahl L; Mueller AM; Zoennchen B; Dluczek S; Halbich C; Wickenhauser C; Gerloff D; Wurm AA; Behre G; Kretschmer A; Fricke S
    Front Immunol; 2018; 9():2408. PubMed ID: 30405611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
    Loges S; Heil G; Bruweleit M; Schoder V; Butzal M; Fischer U; Gehling UM; Schuch G; Hossfeld DK; Fiedler W
    J Clin Oncol; 2005 Feb; 23(6):1109-17. PubMed ID: 15718307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
    Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
    Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
    Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
    de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
    Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
    Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
    Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis and acute myeloid leukemia.
    Haouas H
    Hematology; 2014 Sep; 19(6):311-23. PubMed ID: 24192539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
    Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
    Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
    Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival?
    Curley C; Durrant S; Kennedy GA
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):285-9. PubMed ID: 23418909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.